Blogs & News Articles

Cannabis Industry Business Professionals Blogs, Press Releases and News Articles from the best journalist in the industry. Stay updated on all news from many online cannabis news outlets, on MjLink.com

The addition of the analytical testing platform will allow the company to rapidly develop and launch new edibles products

AgraFlora Organics acquired the HPLC equipment in consideration for the issuance of 10 million common shares at $0.03 per each

AgraFlora Organics International Inc () (FRA:PU31) (OTCPINK:AGFAF) has acquired High Performance Liquid Chromatography (HPLC) equipment for its 51,000-square-foot, fully automated edibles manufacturing facility in Winnipeg, Manitoba.

The company said the addition of an Agilent HPLC driven analytical testing platform at the edibles facility will allow it to rapidly develop and launch new edibles products which have already been formulated.

"Implementing this suite of HPLC analytical equipment into our production strategy will reduce our 3rd party product testing costs, while improving product safety and quality by allowing us to continuously monitor edible production to ensure quality standards are being met,” said James Fletcher, co-founder and operational manager for Edibles and Infusions Corporation, a subsidiary that runs the plant, in a statement.

READ: Agraflora Organics responds to Health Canada's RMI regarding its standard processing license application for edibles facility

“This should also greatly improve our speed to market with unique SKU’s and allow us to offer some of the most price competitive products in the market,” Fletcher added.

As part of the loan, the group's Delta Facility will receive $5,000,000 which will provide full funding to the licensed cultivation areas and will allow the team to bring their first crop of low cost, high potency cannabis to market

The curated portfolio of elite genetics at the Delta facility has been tailored to work with PSC's Delta-based infrastructure and utilizing 422,828 square foot of cultivation space

() (FRA:PU31) (OTCPINK:AGFAF) said that Propagation Services Canada Inc. (PSC), its flagship cultivation asset located in Delta, British Columbia has received an agriculture loan to bring its cannabis cultivation to market and continue Phase 1 of the company’s cultivation strategy.

As part of the loan, the group's Delta Facility will receive $5,000,000 which will provide full funding to the licensed cultivation areas and will allow the PSC team to bring their first crop of low cost, high potency cannabis to market, on a wholesale basis, in Q1 2021.

READ: Agraflora Organics responds to Health Canada's RMI regarding its standard processing license application for edibles facility in Winnipeg

The curated portfolio of elite genetics at the Delta facility has been tailored to work with PSC's Delta-based infrastructure and utilizing 422,828 square foot of cultivation space with state-of-the-art semi-pressurized, semi-open Venlo greenhouses.

In a statement, the AgraFlora board of directors commented: “Having a fully-funded Phase 1 cultivation strategy allows us to deliver high potency cannabis strains in 2021. As partners at PSC, we have full confidence in the Houwelings family's ability to achieve this strategy, given their long history of high-quality agricultural production in low-cost environments, as well as the healthy condition of our award-winning genetics.”

The company said the RMI (request for more information) response is a key step towards achieving the coveted manufacturing license for the 51,000-square-foot, fully automated facility

The company currently uses it Health Canada R&D license to dial in formulations for cannabis-activated gummies, hard candy, and sugar-free variants 

Agraflora Organics International Inc () (OCTMKTS:AGFAF) has submitted a formal response to Health Canada's first request for more information (RMI) regarding the standard processing licence application for Agraflora's 51,000-square-foot, fully automated edibles manufacturing facility in Winnipeg, Manitoba. 

In a statement Friday, the company said the RMI response is a key step towards achieving the standard processing license for the edibles facility. Agraflora in May submitted its site evidence package to Health Canada for the manufacturing license.

AgraFlora noted that on August 27 it launched research and development trials through its Health Canada R&D license to dial in formulations for cannabis-activated pectin and gelatin gummies, hard candy, and sugar-free variants. 

READ: AgraFlora says subsidiary Farmako in distribution agreement with Adjupharm to supply medical cannabis in Germany

The Vancouver-based company said it is currently in discussions with multiple Canadian cannabis companies with respect to product development and formulation as an R&D service. It believes that R&D services contracts are a critical path to long-term production relationships.

Adjupharm, the German subsidiary of IM Cannabis Corp, will provide EU Good Manufacturing Practice quality medical cannabis to Farmako for a three-year term

Farmako will distribute the products in Germany to patients under the IMC brand to its established network of German pharmacies

AgraFlora Organics International Inc () said its subsidiary Farmako GmbH has entered into a binding distribution agreement with Adjupharm GmbH to supply medical cannabis in Germany. 

Adjupharm, the German subsidiary of (), will provide EU Good Manufacturing Practice (GMP) quality medical cannabis to Farmako for a three-year term, according to a statement.

Farmako will distribute the products in Germany to patients under the brand to its established network of German pharmacies. The first products are expected to launch in October 2020.

READ: AgraFlora says Farmako subsidiary secures added supply of EU-GMP certified medical cannabis from ZenPharm

The products provided by Adjupharm and distributed by Farmako include initially high potency THC flower. The portfolio is expected to be enhanced throughout the first quarter of 2021 by balanced THC and CBD flower as well as CBD dominant flower.

The company said the agreement will facilitate the distribution of 1,500 kilograms of cannabis flower by Farmako in Germany over a three-year term

Farmako CEO Katrin Eckmans said it is the compnay's intention to establish partnerships with "reliable suppliers and ensure high quality and sustainable supply at a fair price range to German patients"

AgraFlora Organics International Inc () (OCTMKTS:AGFAF) said on Tuesday that its subsidiary Farmako GmbH has executed a binding supply agreement with ZenPharm Limited, a subsidiary of Global Inc (), to secure additional medical cannabis stock.

As result of the supply agreement, ZenPharm will supply EU Good Manufacturing Practice (GMP) quality medical cannabis flower cultivated by to Farmako for distribution to medical cannabis patients in Germany. The agreement will facilitate the distribution of 1,500 kilograms of cannabis flower by Farmako in Germany over a three-year term, said the company.

Farmako will distribute the products to its established network of German pharmacies and the products will carry Farmako’s branding, a key step in building “brand awareness and loyalty” with physicians, pharmacists and patients, noted the company. The products initially include high potency THC flower and balanced THC and CBD flower, two product categories that management believes are in highest demand in Germany. Shipments to Farmako are expected to start in November 2020.

READ: AgraFlora Organics expects first harvest at its Delta greenhouse in fourth quarter 2020

QAAFI received sativa seeds for a tissue culture program designed to enable high volume and pathogen-resistant plant cultivation for medicinal purposes

The firm inked a collaborative research pact in March 2019 with the University of Queensland for an 18-month, 'proof-of-concept' program

Asterion Cannabis Inc said Thursday its research partner had received sativa seeds for a tissue culture program designed to enable high volume and pathogen-resistant plant cultivation for medicinal purposes.

The Vancouver-based company said the seeds were received by the University of Queensland’s Queensland Alliance for Agriculture and Food Innovation (QAAFI) last week.

QAAFI has begun the program, which is aiming to expedite clonal propagation of elite sections of marijuana plants to allow for high-volume and uniform plant cultivation. Clonal propagation is the multiplication of genetically identical copies of individual plants.

READ: Asterion Cannabis updates on milestones in bid to become world’s largest pharma-grade medicinal cannabis supplier

In a statement, Asterion CEO Steven Van Deventer told shareholders that the firm was pleased that all the required regulatory approvals were received and the seeds are now in QAAFI’s possession. 

The company said it has now dialed in formulations for cannabis activated pectin and gelatin gummies, hard candy and sugar-free variants

Interior of the 51,000-square-foot fully-automated edibles manufacturing facility

AgraFlora Organics International Inc () (OCTMKTS:AGFAF) said it has received a necessary CRA tax license and is now creating test cannabis edibles products through its Health Canada licensed research & development (R&D) lab at the group’s edibles manufacturing facility in Winnipeg, Manitoba.

The company said through its R&D license it has now dialed in formulations for cannabis activated pectin and gelatin gummies, hard candy and sugar-free variants.

READ: AgraFlora Organics expects first harvest at its Delta greenhouse in fourth quarter 2020

"As part of the R&D program, we have begun a testing project with Agilent to improve testing standards, methods, and ensure consistent quality. Our efficient and highly automated R&D production allows us to provide a variety of sample products for our prospective clients to try for their established brands,” said James Fletcher, one of the founders and the operational manager of Edibles and Infusions Corporation, a joint venture formed between AgraFlora and one of North America’s leading confectionery manufacturing families.

AgraFlora also said it submitted its site evidence package to Health Canada for a processing license on May 28, adding that it is in regular contact with the body and remains committed to the timeline of receiving the license in the fourth quarter of 2020.

The group said the "elite genetics" at the Delta facility will yield up to 44 varieties of strains to offer its wholesale clients a “robust product offering"

AgraFlora is in a joint venture with Propagation Services Canada Inc, which operates a 2.2 million-square-foot greenhouse complex in Delta, British Columbia

AgraFlora Organics International Inc () (OCTMKTS:AGFAF) has provided an update on progress at its flagship cultivation asset in Delta, British Columbia which embarked on planting using a curated portfolio of live-plant genetics in June this year.

Vancouver-based AgraFlora said the Delta facility expects to see its first harvest early in the fourth quarter of this year, with the first product available for sale of “low-cost, high potency cannabis strains” in the first quarter of 2021 on a wholesale basis. The company is in a joint venture with Propagation Services Canada Inc, which operates the 2.2 million-square-foot greenhouse complex in Delta, British Columbia.

AgraFlora said the "elite genetics" at the Delta facility has been tweaked to work with Propagation Services Canada's cultivation program and is expected to yield up to 44 varieties of strains to offer to its wholesale clients a “robust product offering,” while maintaining “strong cannabinoid and terpene content” plant yield every year.

READ: AgraFlora Organics International to exchange $3 million of debentures for shares

viewCannabis One Holdings Inc.

The group noted that Mohamed brings over 20 years of private and public sector experience having built an exceptional reputation in business development, capital markets, operational streamlining, mergers, acquisitions, and internal audit

He currently serves as chief executive officer and a director of Softlab9 Technologies Inc.

() has announced the appointment of Rahim Mohamed to its board as an independent director as the company proceeds with its strategic rebranding to INDVR Brands Inc.

The group noted that Mohamed brings over 20 years of private and public sector experience having built an exceptional reputation in business development, capital markets, operational streamlining, mergers, acquisitions, and internal audits.

READ:Cannabis One appoints Alnoor Nathoo to board amid two executive-level departures

Mohamed, who is a member of the Private Capital Markets Association of Canada (PCMA) - formerly known as Exempt Market Dealers Association of Canada (EMDA) - currently serves as chief executive officer and a director of Softlab9 Technologies Inc.

viewAgraFlora Organics International Inc.

The firm said it agreed with holders of its 10% senior unsecured convertible debentures due March 12, 2021, that provides for the purchase of $3 million aggregate principal amount of the debentures

AgraFlora grows, distributes and markets premium cannabis and cannabis-infused products

Agraflora Organics International Inc () (OCTMKTS:AGFAF) has said it is exchanging $3 million worth of debentures for shares in the company.

The firm said it agreed with holders of its 10% senior unsecured convertible debentures due March 12, 2021, that provides for the purchase of $3 million aggregate principal amount of the debentures.

The cannabis company will distribute nearly 55 million shares priced at C$0.05472, which is the daily volume-weighted average price of shares between June 24, 2020, and June 30, 2020.

AgraFlora Organics International Inc. -

viewCannabis One Holdings Inc.

Cannabis One (CSE: CBIS) President and Interim CEO Joshua Mann joined Steve Darling from Proactive Vancouver with news the company has changed up their board of directors. Mr Alnoor Nathoo has joined the board and Mann talks about the experience he brings.

Mann also discusses his role changing as he takes over as CEO and also why the company had decided to move away from Cannabis One, rebranding as INDVR Brands.

CSE:CBIS

Market: CSE
Market Cap: $6.27 m
Follow

View company profile

Highland Grow is licensed to cultivate, process, and distribute cannabis from its facility in Antigonish, Nova Scotia

The personnel changes come as the company prepares to strategically rebrand itself INDVR Brands

Nathoo is principal of a hotel development company that has developed and sold over 10 hotels across Canada 

Cannabis One Holdings Inc () (OTCMKTS:CAAOF) announced Tuesday the appointment of Alnoor Nathoo to its board of directors, one of several new additions the company said it plans to make. 

The company also announced two resignations, that of board director Bernard Radochonski and interim CFO Theresa Mohan. Radochonski still remains a large shareholder and long-standing supporter of the company, the group noted.

The executive-level personnel changes come as Cannabis One prepares to strategically rebrand itself INDVR Brands Inc in a bid to better reflect its cannabis distribution business model.

READ: Cannabis One to transform into fully licensed Colorado operator as it cuts deal to acquire Cannabis Corp

In a statement, Cannabis One noted that Nathoo brings a wealth of public and private company experience. He is the principal of a privately held hotel development company which over the past two decades has developed and sold over 10 hotels across Canada. 

The company also announced that CEO Jeffrey Mascio has resigned from the Cannabis One leadership team as well as the board of directors effective immediately but remain involved with the company in an executive advisory role

The Vancouver-based company is advancing a “House of Brands” model that aggregates and optimizes popular cannabis names in North America

Cannabis One Holdings Inc () (OTCMKTS:CAAOF) has announced plans to change its name to INDVR Brands Inc in a bid to better reflect its cannabis distribution business model.

The Vancouver-based company is advancing a “House of Brands” model that aggregates and optimizes popular cannabis names in North America. It also owns a retail storefront in Colorado called The Joint, which was ranked the number one dispensary in the state by Leafly for three consecutive years.

The company also announced that CEO Jeffrey Mascio has resigned from the Cannabis One leadership team as well as the board of directors effective immediately. Mascio will remain involved with the company in an executive advisory role and the company's president Joshua Mann will take up the interim CEO position.

In a statement on Friday, Mann said that directors and executive management team have collectively decided that its current name does not properly reflect its business or its business model. The name change will not affect the firm’s existing share structure or shareholder rights, the group said.

A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
A glance at some of the day's highlights from the Proactive Investors US and Canada newswires
Post-closing, Biome Grow will become MYM’s largest shareholder with a 19% stake in the company

The firm aims to construct a 4.3 million sq ft (40 hectares) facility, which will be built in three phases

Asterion aims to have an initial product ready with revenues within 24 months of breaking ground

Asterion Cannabis Inc outlined the various significant milestones achieved as the private firm continues its bid to build the world’s largest glasshouse medicinal cannabis production facility in Australia.

In a lengthy investor update, Asterion, which is currently raising C$10 million via a placing, highlighted that in April last year, it inked a definitive deal to buy 75 acres of land in Toowoomba, adjacent to the Toowoomba Wellcamp Airport in Queensland.

READ: Asterion Cannabis launches C$10M brokered private placement

The firm aims to construct a 4.3 million sq ft (40 hectares) facility, which will be built in three phases - the first and second phases being 10 hectares each.

It will include full extraction and processing equipment as well as a research and development (R&D) facility.

The company is currently in talks with potential buyers to determine the optimal sales mix of CBD isolate, CBD distillate and CBD crude oil

The CBD oil was produced from around 10,000 kilograms of hemp biomass that was run through the firm's proprietary pre-extraction processes

AgraFlora Organics International Inc () () revealed that it has now produced around 1,000 kg of CBD oil with its biomass partner MicroC45, which it is preparing to sell this quarter.

The company said it is currently in talks with potential buyers to determine the optimal sales mix of CBD Isolate, CBD Distillate and CBD Crude Oil and expects to close its first bulk transactions this quarter.

READ: AgraFlora Organics International unveils partnership with MicroC45 Inc for growing hemp at Ontario farm

In June this year, AgraFlora struck a cultivation partnership with MicroC45 for growing hemp in Ontario, Canada. MicroC45 has a proprietary separation process that results in higher extraction value and ultimately a greater yield of major and minor cannabinoids.

The group said the CBD oil was produced from approximately 10,000 kilograms of hemp biomass that was run through the firm's proprietary pre-extraction processes.